The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...

The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...

The investigational insulin-only iLet Bionic Pancreas (Beta Bionics) reduced A1c without increasing hypoglycemia in adults and children with type 1 diabetes with greater automation than currently ...

The trial achieved key primary and secondary endpoints, demonstrating improved outcomes over standard of care for people living with type 1 diabetes. The study population — 440 adults and children 6 ...

CONCORD, MA / ACCESSWIRE / May 22, 2023 / Beta Bionics, Inc. - a medical technology company focused on diabetes - announces FDA 510(k) clearance and the commercial launch of the iLet Bionic Pancreas.

The US Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes. These two devices, ...

The US Food and Drug Administration (FDA) has cleared Beta Bionics's iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and older with type 1 diabetes. Working together with a ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A third-generation bionic pancreas that allows for integration with two different commercially ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...